- 2010-03-03 Martek Extends Multi-Year Sole-Source License and Supply Agreement with Danone
- 2010-03-03 Abbott to Collaborate with GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy
- 2010-03-03 Stemgent Invests $4.5 Million, Announces Formation Of Ubiquigent, A New Uk-Listed Biotechnology Company Based In Dundee, Scotland
- 2010-03-03 Syntarga Announces Two Antibody-Drug Conjugate Collaborations with Top-tier Biopharmaceutical Companies
- 2010-03-03 Paladin and SpePharm Announce New Strategic Relationship and Financing
- 2010-03-03 NicOx and Bausch + Lomb Announce Worldwide Licensing Agreement for NCX 116
- 2010-03-02 Revised Shire licensing deal for Juvista
- 2010-03-02 Shionogi Enters into Exclusive License Agreement with QuatRx Pharmaceuticals to Market Ospemifene
- 2010-03-02 Zealand Pharma and PolyTherics Enter Collaboration Agreement for Novel Optimised Biopharmaceuticals
- 2010-03-02 Metabion Licenses Polyplus-transfection's ZNA Technology for Research and Diagnostic Development
